Competes with plasminogen for binding to keratinocytes, reducing UV-induced plasminogen activation and downstream arachidonic acid signalling that triggers melanogenesis.
Concerns it helps
Concern
Strength
Studies
What the research says
Dark spots & hyperpigmentation
Strong
2
TXA's UV-induced plasmin inhibition mechanism extends to general sun-induced hyperpigmentation (solar lentigines, chronic photoaging pigmentation). Clinical evidence less extensive than for melasma but mechanism…
Post-acne marks
Strong
—
PIH shares partial mechanism with melasma — plasminogen-mediated inflammatory melanogenesis is relevant to both. Topical and oral TXA have documented efficacy for PIH though direct RCT evidence is less extensive than…
Redness & sensitivity
Relevant
1
Emerging evidence for topical TXA in erythrotelangiectatic rosacea via antiangiogenic mechanism. Not primary rosacea treatment (primary: azelaic, metronidazole, ivermectin, doxycycline) but mechanism-appropriate adjunct…
No known conflicts — Tranexamic Acid isn’t flagged against any concern or skin condition.
Strength reflects the ingredient’s effect on each concern; study counts match research whose findings relate to that concern.
The research
Tranexamic Acid is a brightening agent backed by a moderate body of supporting evidence (evidence tier 2 of 4). We track 14 studies for it, 9 reporting a positive effect. It is typically effective at 2–5% in a formulation.
Dermatologic Therapy · 2017 · meta analysis · n=667
Meta-analysis (n=667): Early systematic review demonstrating MASI decrease of 1.60 95% CI 1.20 2.00 p=0.001 with TXA and additional 0.94 decrease when added to routine treatment; established evidence base for TXA in melasma.
Indian Journal of Dermatology, Venereology and Leprology · 2022 · meta analysis
Meta-analysis: PIVOTAL network meta analysis establishing optimal oral dose as 250 mg three times daily 750 mg total daily for 12 weeks with 250 mg twice daily acceptable alternative.
Journal of the American Academy of Dermatology · 2018 · rct
Randomized, double-blind, placebo-controlled trial in moderate-to-severe melasma: oral tranexamic acid 250 mg twice daily significantly reduced modified MASI versus placebo over 3 months; pigmentation partially returned after discontinuation; treatment was well tolerated with no serious adverse events.
+ 8 more studies in our evidence base.
Products with Tranexamic Acid
In 200 products — most often serums (100), moisturizers (43), masks (13), from $3.76 to $304.80. Set up a profile to rank these for your skin. Click any product to learn more.
SKIN1004 Madagascar Centella Tone Brightening Capsule Ampoule 100ml is a brightening serum by SKIN1004. Key ingredients include Water, Butylene Glycol, Niacinamide.
Day Dream Vitamin C + Niacinamide Tone & Texture Serum is a brightening serum by Bubble. Key ingredients include Water, Coco-Caprylate/Caprate, Glycerin.
PM Blemish Aftercare Brightening Patches is a antioxidant serum by PanOxyl. Key ingredients include Niacinamide, Tranexamic Acid, Magnesium Ascorbyl Phosphate.